Methods, compositions, and delivery systems for therapeutic skin treatments
US-2024390236-A1 · Nov 28, 2024 · US
US9795548B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9795548-B2 |
| Application number | US-201214381024-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 2, 2012 |
| Priority date | Mar 2, 2012 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are compositions comprising isopropyl magnolol; a surfactant system; and an orally acceptable carrier, together with methods of making and using the same.
Opening claim text (preview).
The invention claimed is: 1. An oral care composition comprising: isopropyl magnolol; an orally acceptable carrier; and a surfactant system, wherein the surfactant system comprises a surfactant having an HLB value greater than 10 and a co-surfactant having an HLB value of less than about 10, the isopropyl magnolol is present in the amount of from about 0.1% to about 3% based on the total weight of the composition, the ratio by weight of isopropyl magnolol to the co-surfactant is from about 0.1:1 to about 2:1, the surfactant having an HLB value greater than 10 is sodium lauryl sulfate and the co-surfactant is propylene glycol monocaprylate. 2. The composition of claim 1 , wherein the co-surfactant is present in an amount sufficient to solubilize the isopropyl magnolol in the orally acceptable carrier. 3. The composition of claim 1 , in the form of a toothpaste. 4. The composition of claim 1 , in the form of a mouthrinse. 5. A method of treating a disease or condition of the oral cavity, comprising administering a composition according to claim 1 , to the oral cavity of a subject in need thereof. 6. The method of claim 5 , wherein the disease or condition of the oral cavity is selected from caries, gingivitis, periodontitis, tooth yellowing and halitosis.
Magnolia · CPC title
Solubiliser, Solubilising system · CPC title
Oxygen or sulfur directly attached to an aromatic ring system · CPC title
the alcohol moiety containing more than one hydroxy group · CPC title
Phenols · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.